Mark J. Canet

Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease

Rhiannon N. Hardwick, Craig D. Fisher, Mark J. Canet et al. · Drug Metabolism and Disposition · 2010 · 194 citations · Full text

Variations in ATP-Binding Cassette Transporter Regulation during the Progression of Human Nonalcoholic Fatty Liver Disease

Rhiannon N. Hardwick, Craig D. Fisher, Mark J. Canet et al. · Drug Metabolism and Disposition · 2011 · 138 citations

Altered Regulation of Hepatic Efflux Transporters Disrupts Acetaminophen Disposition in Pediatric Nonalcoholic Steatohepatitis

Mark J. Canet, Matthew D. Merrell, Rhiannon N. Hardwick et al. · Drug Metabolism and Disposition · 2015 · 68 citations · Full text

Modeling Human Nonalcoholic Steatohepatitis-Associated Changes in Drug Transporter Expression Using Experimental Rodent Models

Mark J. Canet, Rhiannon N. Hardwick, April D. Lake et al. · Drug Metabolism and Disposition · 2014 · 67 citations · Full text

Molecular Mechanism of Altered Ezetimibe Disposition in Nonalcoholic Steatohepatitis

Rhiannon N. Hardwick, Craig D. Fisher, Stephanie M. Street et al. · Drug Metabolism and Disposition · 2011 · 66 citations · Full text